Last €63.77 EUR
Change Today +0.77 / 1.23%
Volume 862.0
LLY On Other Exchanges
Symbol
Exchange
Mexico
Sao Paulo
Frankfurt
As of 1:47 PM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitleKey Developments
Kathi Seifert 46 RelationshipsDirector, Member of Compensation Committee and Member of Audit CommitteeFair Trade Commission Fines Pfizer Inc., Merck Sharpe & Dohme, Eli Lilly & Co., Glaxosmithkline plc and Otsuka Group
01/15/09
Douglas Oberhelman 50 RelationshipsDirector, Member of Audit Committee and Member of Finance CommitteeFederal probe could expand to cover Lilly's top-selling drug
03/10/04
Katherine Baicker Ph.D. 15 RelationshipsDirector, Member of Public Policy & Compliance Committee and Member of Audit CommitteeSEC Probing Polish Operations of Lilly
11/13/03

Compensation Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
R. Hoover 54 RelationshipsDirector and Member of Compensation Committee
Karen Horn Ph.D. 108 RelationshipsDirector, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
Ellen Marram 183 RelationshipsLead Independent Director, Chairman of Directors & Corporate Governance Committee and Member of Compensation Committee
Kathi Seifert 46 RelationshipsDirector, Member of Compensation Committee and Member of Audit Committee
LLY Compensation vs. Industry
1.5M
375.3K
Chief Executive Officer
1.0M
256.4K
Chief Financial Officer
Share price activity for ELI LILLY & CO (LLY)
52 Week Price Performance
LLY
Industry Average

Corporate Governance Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
Karen Horn Ph.D. 108 RelationshipsDirector and Member of Compensation Committee
Ellen Marram 183 RelationshipsDirector, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
LLY and Competitor
Insiders vs. External
Board
13%
87%
Eli Lilly and Company
14%
86%
Actavis plc
9%
91%
Abbott Laboratories
8%
92%
Teva Pharmaceutical Industries Limited
14%
86%
AstraZeneca PLC
11%
89%
AbbVie Inc.
Insiders
External Board Members

Executive Committee* - eli lilly & co (LLY)

Name (Connections)Board RelationshipsTitle
Melissa Barnes 0 RelationshipsChief Ethics & Compliance Officer and Senior Vice President of Enterprise Risk Management
Michael Harrington 0 RelationshipsSenior Vice President and General Counsel
Barton Peterson 8 RelationshipsSenior Vice President of Corporate Affairs & Communications and Member of Operations Committee
Management Effectiveness Relative to the Industry
Return on Equity
1.5x
Return on Assets
1.3x
Return on Total Capital
1.5x
TEV/Total Revenue(LTM)
1.5x

Finance Committee* - eli lilly & co (LLY)

Name(Connections)Board RelationshipsTitle
Ralph Alvarez 59 RelationshipsDirector, Member of Public Policy & Compliance Committee, Member of Finance Committee and Member of Science & Technology Committee
William Kaelin Jr., M.D. 145 RelationshipsDirector, Member of Finance Committee and Member of Science & Technology Committee
Douglas Oberhelman 50 RelationshipsDirector, Member of Audit Committee and Member of Finance Committee
Debt To Total Capitalization34.8x
It is important for the finance committee to know when to issue debt or equity.

Committee of Directors* - eli lilly & co (LLY)

Name (Board Relationships)/TitleBoard Affiliations
Karen Horn 108 Relationships
Director, Chairman of Compensation Committee and Member of Directors & Corporate Governance Committee
Ellen Marram 183 Relationships
Lead Independent Director, Chairman of Directors & Corporate Governance Committee and Member of Compensation Committee
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLY:GR €63.77 EUR +0.77

LLY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $47.26 USD +0.17
AbbVie Inc $60.20 USD +0.58
Actavis plc $296.00 USD -0.23
AstraZeneca PLC 4,424 GBp -8.00
Teva Pharmaceutical Industries Ltd $56.36 USD -0.105
View Industry Companies
 

Industry Analysis

LLY

Industry Average

Valuation LLY Industry Range
Price/Earnings 32.0x
Price/Sales 3.9x
Price/Book 4.9x
Price/Cash Flow 33.1x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELI LILLY & CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.